CAMERON KIMBERLY O

No ORCID on file · 63 papers in corpus · active 1996-2004
2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2004

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2003

This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits compris…

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.

2001

Compounds of the formulae (I):- where A, B, D, E, G, Y, Z1 and e are certain specified substituents, are useful for treating obesity, breast cancer, osteroporosis, endometriosis, cardiovascular disease and prostatic disease.